Ing Investment Management »

Trevi Therapeutics shares owned by Ing Investment Management

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by Ing Investment Management from 13F filings

Historical chart of Ing Investment Management investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by Ing Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by Ing Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $46k 13k 3.45
2023-09-30 $38k 18k 2.18
2023-06-30 $42k 18k 2.39

More positions owned by Ing Investment Management

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Apple (AAPL)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Wisdomtree Tr Voya Yld Enhncd (UNIY)
Broadcom (AVGO)
Tesla Motors (TSLA)
salesforce (CRM)
Eli Lilly & Co. (LLY)
Bank of America Corporation (BAC)
Datadog Cl A Com (DDOG)
Mastercard Incorporated Cl A (MA)
Home Depot (HD)

View all positions for Ing Investment Management

Top funds holding Trevi Therapeutics

NEA Management Company
Frazier Life Sciences Management
Rubric Capital Management
Viking Global Investors
VR Adviser
Opaleye Management
BlackRock
Vanguard Group
Logos Global Management
MPM Oncology Impact Management
MAI Wealth Advisors
Rosalind Advisors
Geode Capital Management
Landscape Capital Management
Checkpoint Capital

View all funds holding Trevi Therapeutics